Research Article
Nuclear Transporting Factor 2 as a Novel Biomarker of Head and Neck Squamous Cell Carcinoma and Associated with T/B Cell Receptor Signaling Pathway
Table 1
Patient characteristics in TCGA-HNSCC.
| Clinical characteristics | Total 528 | % |
| Age | | | 61 (average) | | | (19-90) | | | Gender | | | Male | 142 | 26.9 | Female | 386 | 73.1 | Not available | 1 | 0.2 | Status | | | Alive | 329 | 62.3 | Deceased | 199 | 37.7 | Grade | | | G1 | 63 | 11.9 | G2 | 311 | 58.9 | G3 | 125 | 23.7 | G4 | 7 | 1.3 | GX | 18 | 3.4 | Not available | 4 | 0.8 | Stage | | | Stage I | 27 | 5.1 | Stage II | 74 | 14.0 | Stage III | 82 | 15.5 | Stage IV | 270 | 51.1 | Not available | 75 | 14.2 | T classification | | | T0 | 1 | 0.2 | T1 | 49 | 9.3 | T2 | 140 | 26.5 | T3 | 101 | 19.1 | T4 | 175 | 33.1 | TX | 39 | 7.4 | Not available | 23 | 4.4 | M classification | | | M0 | 191 | 36.2 | M1 | 1 | 0.2 | MX | 65 | 12.3 | Not available | 271 | 51.3 | N classification | | | N0 | 180 | 34.1 | N1 | 68 | 12.9 | N2 | 72 | 13.6 | N3 | 8 | 1.5 | NX | 75 | 14.2 | Not available | 25 | 4.7 |
|
|